Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2023-02-03 00:00:00 ET · period of report 2023-02-01 · accession 0001883850-23-000031 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-02-03 | 2023-02-01 | REGN | RYAN ARTHUR F | Dir | S - Sale | $756.13 | -100 | 19.2K | -0.5% | -$75.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-01 | S | D | 2 | $762.17 | 19,247 | D | — | — | (F12) Represents volume-weighted average price of sales of 2 shares of Company stock on February 1, 2023 at prices ranging from $762.15 to $762.19. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price. |
| 2 | Common | Common Stock | 2023-02-01 | S | D | 4 | $760.40 | 19,252 | D | — | — | (F10) Represents volume-weighted average price of sales of 4 shares of Company stock on February 1, 2023 at prices ranging from $760.09 to $760.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price. |
| 3 | Common | Common Stock | 2023-02-01 | S | D | 4 | $759.65 | 19,256 | D | — | — | (F9) Represents volume-weighted average price of sales of 4 shares of Company stock on February 1, 2023 at prices ranging from $759.30 to $759.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price. |
| 4 | Common | Common Stock | 2023-02-01 | S | D | 7 | $758.58 | 19,260 | D | — | — | (F8) Represents volume-weighted average price of sales of 7 shares of Company stock on February 1, 2023 at prices ranging from $758.29 to $758.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price. |
| 5 | Common | Common Stock | 2023-02-01 | S | D | 2 | $757.29 | 19,267 | D | — | — | (F7) Represents volume-weighted average price of sales of 2 shares of Company stock on February 1, 2023 at prices ranging from $757.02 to $757.56. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price. |
| 6 | Common | Common Stock | 2023-02-01 | S | D | 24 | $756.77 | 19,269 | D | — | — | (F6) Represents volume-weighted average price of sales of 24 shares of Company stock on February 1, 2023 at prices ranging from $756.18 to $756.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price. |
| 7 | Common | Common Stock | 2023-02-01 | S | D | 17 | $755.50 | 19,293 | D | — | — | (F5) Represents volume-weighted average price of sales of 17 shares of Company stock on February 1, 2023 at prices ranging from $755.11 to $755.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price. |
| 8 | Common | Common Stock | 2023-02-01 | S | D | 17 | $754.45 | 19,310 | D | — | — | (F4) Represents volume-weighted average price of sales of 17 shares of Company stock on February 1, 2023 at prices ranging from $754.08 to $754.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price. |
| 9 | Common | Common Stock | 2023-02-01 | S | D | 18 | $753.54 | 19,327 | D | — | — | (F3) Represents volume-weighted average price of sales of 18 shares of Company stock on February 1, 2023 at prices ranging from $753.05 to $753.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price. |
| 10 | Common | Common Stock | 2023-02-01 | S | D | 2 | $752.11 | 19,345 | D | — | — | (F2) Represents volume-weighted average price of sales of 2 shares of Company stock on February 1, 2023 at prices ranging from $752.02 to $752.19. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price. |
| 11 | Common | Common Stock | 2023-02-01 | S | D | 3 | $761.58 | 19,249 | D | — | — | (F11) Represents volume-weighted average price of sales of 3 shares of Company stock on February 1, 2023 at prices ranging from $761.49 to $761.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price. |